MONTREAL, Feb. 6, 2025 /CNW/ - Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that it has closed a share purchase agreement (the "Transaction") with ...

The recent 12% drop in Valeo Pharma Inc.'s (TSE:VPH) stock could come as a blow to insiders who purchased CA$372k worth of stock at an average buy price of CA$0.57 over the past 12 months. Insiders ...

MONTREAL, Oct. 1, 2024 /CNW/ - Valeo Pharma Inc. (VPH:CA) (TSX: VPH) (FSE: VP2), a Canadian pharmaceutical company, announced today that the Québec Superior Court (Commercial Division) (the "Court") ...

Hesperco TM capsules can be taken to support immune system Valeo Pharma enters into agreement with Ingenew Pharma Inc. MONTREAL, Aug. 24, 2020 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) (FSE: VP2) ...

MONTREAL, July 13, 2021 /PRNewswire/ - Valeo Pharma Inc. (CSE:VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that Redesca™ and Redesca ...

In the last year, multiple insiders have substantially increased their holdings of Valeo Pharma Inc. (TSE:VPH) stock, indicating that insiders' optimism about the company's prospects has increased.

MONTREAL, Jan. 18, 2021 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today the appointment of Mr.

MONTREAL, June 22, 2021 /PRNewswire/ - Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that commercialization of ...

Looking for the most shorted stocks?